Antibiotic use plunged during pandemic
The use of antibiotics fell sharply during the COVID-19 pandemic, according to a new study in France. The research suggests that antimicrobial prescriptions declined during periods of social… read more.
The use of antibiotics fell sharply during the COVID-19 pandemic, according to a new study in France. The research suggests that antimicrobial prescriptions declined during periods of social… read more.
Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers from the Yong Loo Lin School of Medicine, National… read more.
A new study highlights recent, but fluctuating, growth in global human antibiotic consumption, one of the main drivers of growing antimicrobial resistance (AMR). AMR results in infections that… read more.
Speaking at the World Health Assembly, authors of a new Lancet Series call for urgent global action on antimicrobial resistance (AMR), and ensuring sustainable access to antibiotics through:… read more.
Qi “Tony” Zhou, a researcher in Purdue University’s College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established… read more.
Despite progress in combating antimicrobial resistance (AMR) in the USA since its peak during the COVID-19 pandemic, hospital-acquired AMR infections remain well above pre-pandemic levels, according to a… read more.
28th EAHP Congress Highlights The theme of the 28th EAHP congress was Sustainable healthcare – opportunities and strategies. Management of antimicrobial resistance (AMR) and good antimicrobial stewardship are… read more.
ASHP Midyear Clinical Meeting – Highlights Antimicrobial resistance (AMR) caused an estimated five million deaths in 2019 and by 2050 this is likely to rise to 10 million… read more.
New research from the University of Georgia found that fungal infections account for $6.7 billion in health care spending in 2018. And that’s just the cases that were… read more.
The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs’ benefits among the wider population, a new study suggests.